- By Editorial Team
IMVIS (Infinite Medical Ventures Imaging System) digitises the traditional slit lamp exam, a core part of eye examinations that has barely changed in over 100 years. Using IMVIS, high-definition, fully 3D eye images can be captured, reviewed and shared remotely – live or retrospectively – on smartphones, tablets, and computers, anywhere in the world. The system is ready for AI machine learning, creating structured, objective datasets that will power future diagnostic algorithms and smart decision-support tools. IMVIS lays the groundwork for AI-driven healthcare in ophthalmology and “is set to slash waiting lists, reduce clinician workload, and improve national and global access to specialist care”. Developed by Sheraz Daya, Medical Director at Centre for Sight, and retinal surgeon Professor Tom Williamson, IMVIS is now in use at Centre for Sight’s East Grinstead and Oxshott centres, with London installations coming soon at Harley Street and London Lauriston Clinic. “This is a complete digital transformation,” said Sheraz Daya. “IMVIS makes fully remote eye care possible today while creating the clinical infrastructure for AI-driven diagnostics tomorrow. It’s more than an upgrade – it’s a new standard.”

“IMVIS will fundamentally change how we deliver eye care,” said Professor Williamson. “It will help reduce waiting times, make eye care more accessible, and open the door to scalable, AI-supported clinical decision-making”. The breakthrough comes as ophthalmology faces rising pressures from ageing populations, limited capacity, and overstretched clinical teams. IMVIS offers a faster, more flexible alternative to the in-person slit lamp exam, enabling documentation, real-time telemedicine, remote collaboration and more efficient patient management. By producing accurate 3D video imagery at every visit, IMVIS also eliminates the need for outdated clinical drawings and low-quality 2D images. The system’s datasets are perfectly suited for future artificial intelligence integration and medical education, supporting the development of new training models and diagnostic tools. A fundamental goal of the project has been to make the device affordable enough to be implemented by all eye care providers. IMVIS has been developed in partnership with medical innovation catalyst, Infinite Medical Ventures. Infinite Medical Ventures is a distinct technology development incubator founded by Professor Tom Williamson and Sheraz Daya to take innovative ideas from doctors and clinicians through the process of development all the way to commercialisation.

